Patent details

EP2362767 Title: FORMULATIONS OF SINGLE DOMAIN ANTIGEN BINDING MOLECULES

Basic Information

Publication number:
EP2362767
PCT Application Number:
US2009062611
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP097486252
PCT Publication Number:
WO2010077422
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
FORMULATIONS OF SINGLE DOMAIN ANTIGEN BINDING MOLECULES
French Title of Invention:
FORMULATIONS DE MOLÉCULES DE LIAISON D'ANTIGÈNE MONODOMAINES
German Title of Invention:
FORMULIERUNGEN VON EINZELDOMÄNEN-ANTIGEN-BINDUNGSMOLEKÜLEN
SPC Number:

Dates

Filing date:
29/10/2009
Grant date:
06/12/2017
EP Publication Date:
07/09/2011
PCT Publication Date:
08/07/2010
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/12/2017
EP B1 Publication Date:
06/12/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
29/10/2018
Expiration date:
29/10/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/11/2017
 
 

Name:
Ablynx N.V.
Address:
Technologiepark 21, 9052 Ghent-Zwijnaarde, Belgium (BE)

Inventor

1

Name:
PAULSON, Andrea
Address:
United States (US)

2

Name:
FERNANDEZ, Jason, E.
Address:
United States (US)

3

Name:
DIXON, Daniel, A.
Address:
United States (US)

Priority

Priority Number:
109474 P
Priority Date:
29/10/2008
Priority Country:
United States (US)

Classification

IPC classification:
G06F 19/00; A61K 9/00; A61K 9/16; A61K 9/19; A61K 39/00; A61K 39/395; A61K 47/26; A61P 35/00; C07K 16/18; C07K 16/24; G01N 33/15; G06Q 99/00; A61K 47/10;

Publication

European Patent Bulletin

Issue number:
201749
Publication date:
06/12/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
28/02/2019 Outgoing Correspondence 1